How we Helped Pharma Giant Tackle Patient Non-Adherence To Treatment Protocols

Summary

Client Details:

The multinational pharma giant, headquartered in the USA, with annual revenue of $2Bn+, operated in the rare disease market segment. 

Challenges:

The company was facing a significant revenue loss due to patient non-adherence to treatment protocols and high churn rates. The company had limited visibility into patient behavior, making it challenging to understand the reasons behind non-adherence and churn. 

Solutions:

Quantzig collaborated with the pharmaceutical giant to integrate and analyze diverse data sources, including electronic medical records, patient surveys, prescription data, and demographic information. Through the analysis of patient journey mapping combined with digital health for pharma solutions, we successfully identified specific points in the healthcare process where there was a higher risk of patient churn or non-adherence to treatment protocols. We recommended a set of next steps to prevent churn by patient segment and enabled the leadership team to make strategic decisions to help improve revenue. Our patient grouping and segmentation solution helped the client to understand the specific patient needs and preferences. By tailoring communication, personalized care, targeted interventions based on these groups, the client enhanced patient satisfaction, loyalty, and engagement, thereby reducing churn.

Impact Delivered

All of the above initiatives resulted in:

• 12% Reduction in patient churn
• 10% increase in revenue
• Effective centralized decision-making

Industry Overview

• The US pharmaceutical market is the largest in the world in terms of revenue. In 2020, the pharmaceutical industry in the USA generated approximately USD 534.21 billion in prescription drug sales.
• The economic contribution of the U.S. pharmaceutical industry encompasses direct employment, research and development investments, manufacturing activities, exports, tax revenue, healthcare expenditure, academic collaborations, and the growth of supporting industries. Its contribution extends beyond the pharmaceutical companies themselves, positively impacting the broader economy and society as a whole. 
• Patient journey mapping combined with digital health for pharma solutions is instrumental in improving patient experiences, driving better healthcare outcomes, and promoting innovation within the USA pharmaceutical industry. These approaches have the potential to transform the way healthcare is delivered, leading to more patient-centric and effective treatments. 

About the Client

• The multinational pharma giant, headquartered in the USA, with an annual revenue of $2Bn+, operated in the rare disease market segment. 
• Recognizing the decreasing patient adherence to treatment protocols, the client aimed to delve into the patient’s journey to identify the underlying causes and make informed strategic decisions.
• They sought to leverage patient journey mapping and digital health for pharma to gain insights and improve patient adherence. 
• By integrating digital health for pharma solutions into the patient journey mapping process, the client aimed to gather real-time data on patient behaviors, treatment compliance, and medication adherence. These digital tools allowed for continuous monitoring, personalized interventions, and timely feedback to address barriers and motivate patients to adhere to their treatment protocols. 

Challenges

• Patient adherence to treatment protocols was low. Despite extensive efforts to analyze the issue, the client struggled to pinpoint the root causes behind the persistently low patient adherence and high churn rates within their treatment protocols.  
• By employing patient journey mapping techniques, they aimed to gain a comprehensive understanding of the different touchpoints and experiences patients encounters throughout their treatment journey, with a specific focus on identifying barriers to adherence and reasons for churn. Incorporating digital health for pharma solutions, the client sought to leverage technology to enhance patient engagement, provide personalized support, and track medication adherence in real-time, ultimately addressing the challenges associated with low adherence and churn rates. 
• The lack of centralized access to overall market dynamics and patient segment-level insights hindered the leadership team’s ability to plan for the next steps to improve adherence. By leveraging patient journey mapping and digital health for pharma solutions, the leadership team aimed to gain a granular understanding of the patient experience, uncover adherence challenges, and market trends, enabling them to make informed decisions and drive impactful improvements in patient adherence. The lack of centralized access to market dynamics and patient segment-level insights created a fragmented view of the patient journey, making it challenging for the leadership team to identify touchpoints where interventions could be implemented effectively.

Solutions

• Quantzig analyzed the diagnostic data extensively, using it to create a comprehensive mapping of various patient journeys. By identifying patterns and similarities, they were able to cluster patients into distinct behavioral groups based on their healthcare experiences. It helped our team better understand the diverse needs, preferences, and behaviors of its clientele, leading to more personalized and effective healthcare solutions. Our incorporation of patient journey mapping and digital health for pharma enabled the client to transform diagnostic data into actionable information, facilitating the identification of critical touchpoints where technology could be leveraged to enhance patient engagement and adherence. 
• Through the analysis of patient journey maps, we successfully identified specific points in the healthcare process where there was a higher risk of patient churn or non-adherence to treatment protocols. This valuable insight enabled them to proactively address potential obstacles and design target interventions to mitigate these risks. By understanding the pain points and challenges faced by different patient segments, our team could implement tailored strategies to improve patient engagement, adherence, and retention. This data-driven approach ultimately led to better patient outcomes and enhanced patient satisfaction, as patients received the necessary support and interventions at critical stages of their healthcare journey.
• Finally, Quantzig recommended a set of next steps to prevent churn by patient segment and enabled the leadership team to make strategic decisions to help improve revenue. We recommended the implementation of digital tools, such as mobile apps, or patient portals, to enhance patient education and facilitate medication reminders and adherence tracking. 
• Through extensive data analysis and patient grouping and segmentation, our team was able to uncover patterns and reasons behind patient non-adherence, such as complex medication regimens, lack of understanding, or side effects. By pinpointing these key issues, we enabled the leadership team to develop targeted interventions and strategies to reduce patient non-adherence and mitigate revenue loss. The patient journey mapping approach combined with digital health for pharma solutions empowered the pharma giant to create a seamless and engaging patient experience, resulting in improved treatment adherence, reduced churn, and enhanced revenue generation.